HUP0104251A2 - Flutikazont tartalmazó, fokozott érösszehúzó hatású lemosószerek és eljárás azok előállítására - Google Patents

Flutikazont tartalmazó, fokozott érösszehúzó hatású lemosószerek és eljárás azok előállítására

Info

Publication number
HUP0104251A2
HUP0104251A2 HU0104251A HUP0104251A HUP0104251A2 HU P0104251 A2 HUP0104251 A2 HU P0104251A2 HU 0104251 A HU0104251 A HU 0104251A HU P0104251 A HUP0104251 A HU P0104251A HU P0104251 A2 HUP0104251 A2 HU P0104251A2
Authority
HU
Hungary
Prior art keywords
meg
producing
fluticasone
vasoconstrictor activity
fatty alcohol
Prior art date
Application number
HU0104251A
Other languages
English (en)
Inventor
Gordon J. Dow
Keith Arthur Johnson
Frances Furr Kelly
Robert William Lathrop
Rukmini Rajagopalan
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10841015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0104251(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HUP0104251A2 publication Critical patent/HUP0104251A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

A tal lm ny szerinti lemosószerek - 0,005-1,0 t"meg%-ban flutikazontvagy annak farmakológiai szempontból elfogadható sój t vagy észterét,- 1,0-10,0 t"meg%-ban 14-20 szénatomos zsíralkoholt vagy C14-C20-zsíralkoholelegyet, - 1,0-5,0 t"meg%-ban legal bb egy bőrkondicion lószert, - 5,0-15,0 t"meg%-ban propilénglikolt, - legfeljebb 10,0t"meg%-ban sv nyolajat vagy l gy fehérparaffint és - a 100 t"meg%eléréséhez szükséges mennyiségben vizet tartalmaznak. A tal lm nyszerinti lemosószereket úgy llítj k elő, hogy a komponenseket magasabbhőmérsékleten "sszekeverik, majd az így kapott elegyet lehűtik vagyfelmelegítik. Ó
HU0104251A 1998-10-22 1999-10-20 Flutikazont tartalmazó, fokozott érösszehúzó hatású lemosószerek és eljárás azok előállítására HUP0104251A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9823036.0A GB9823036D0 (en) 1998-10-22 1998-10-22 Fluticasone lotion having improved vasoconstrictor activity
PCT/GB1999/003472 WO2000024401A1 (en) 1998-10-22 1999-10-20 Fluticasone lotion having improved vasoconstrictor activity

Publications (1)

Publication Number Publication Date
HUP0104251A2 true HUP0104251A2 (hu) 2002-04-29

Family

ID=10841015

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104251A HUP0104251A2 (hu) 1998-10-22 1999-10-20 Flutikazont tartalmazó, fokozott érösszehúzó hatású lemosószerek és eljárás azok előállítására

Country Status (18)

Country Link
US (1) US7300669B2 (hu)
EP (1) EP1123101A1 (hu)
JP (1) JP2002528418A (hu)
KR (1) KR20010073220A (hu)
CN (1) CN1176659C (hu)
AU (1) AU754480B2 (hu)
BR (1) BR9914703A (hu)
CA (1) CA2347109A1 (hu)
CZ (1) CZ20011419A3 (hu)
GB (1) GB9823036D0 (hu)
HU (1) HUP0104251A2 (hu)
IL (1) IL142471A0 (hu)
NO (1) NO20011911D0 (hu)
NZ (1) NZ510949A (hu)
PL (1) PL348029A1 (hu)
TR (1) TR200101109T2 (hu)
WO (1) WO2000024401A1 (hu)
ZA (1) ZA200102971B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR032362A1 (es) * 2000-08-14 2003-11-05 Glaxo Group Ltd Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
US7897587B2 (en) 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
US20090233891A1 (en) * 2008-03-11 2009-09-17 Glenmark Generics Ltd. Pharmaceutical lotion comprising fluticasone propionate
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US20140371179A1 (en) * 2013-06-13 2014-12-18 Professional Compounding Centers Of America Methods and Compositions for Treating Esophageal Diseases
ES2812451T3 (es) 2015-06-18 2021-03-17 Bausch Health Ireland Ltd Composiciones tópicas que comprenden un corticosteroide y un retinoide para tratar la psoriasis
US10653656B2 (en) 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
GB9103764D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Compositions
WO1994014472A1 (en) * 1992-12-22 1994-07-07 The Regents Of The University Of California Method for inhibition of cell adhesion to receptors containing selectins

Also Published As

Publication number Publication date
NO20011911L (no) 2001-04-18
CZ20011419A3 (cs) 2001-09-12
US7300669B2 (en) 2007-11-27
IL142471A0 (en) 2002-03-10
EP1123101A1 (en) 2001-08-16
NO20011911D0 (no) 2001-04-18
CA2347109A1 (en) 2000-05-04
ZA200102971B (en) 2002-06-26
PL348029A1 (en) 2002-05-06
TR200101109T2 (tr) 2001-09-21
US20040176342A1 (en) 2004-09-09
GB9823036D0 (en) 1998-12-16
AU6352499A (en) 2000-05-15
CN1176659C (zh) 2004-11-24
AU754480B2 (en) 2002-11-14
JP2002528418A (ja) 2002-09-03
WO2000024401A1 (en) 2000-05-04
BR9914703A (pt) 2001-07-10
NZ510949A (en) 2003-11-28
CN1326350A (zh) 2001-12-12
KR20010073220A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
DK0794764T3 (da) Topiske hudplejesammensætninger indeholdende fortykkede polyolcarboxylsyreestere som hudkonditionerende midler
BR9908578A (pt) Composição cosmética
BG103335A (en) Application of fumaric acid derivatives
EP0919225A3 (en) Lipid mix for lip product
NZ321429A (en) Complementary compositions like polyol fatty acid polyesters for improving the performance of long-wearing cosmetic products and methods therefore
CA2195419A1 (en) Immunological activity of rhamnolipids
ES2176708T3 (es) Composiciones detergentes.
WO2005000248A3 (en) Compositions and methods for skin conditioning
HUP0104251A2 (hu) Flutikazont tartalmazó, fokozott érösszehúzó hatású lemosószerek és eljárás azok előállítására
DK0623019T3 (da) Medikamenter på basis af docosahexaensyre som midler mod blodpladeaggregation og mod cerebral mangel på essentielle fedtsyr
WO1999027924A3 (fr) Agnim comme agents anti-inflammatoires dans les tissus superficiels des mammiferes
CA2415354A1 (en) Phospholipid derivatives of valproic acid and mixtures thereof
FR2824732B1 (fr) Composition de conditionnement des cheveux comprenant un melange d'alcools gras et procede de traitement cosmetique des cheveux
NO891113L (no) Overflateaktive forbindelser, samt fremgangsmaate for fremstilling av slike.
DE69701530T2 (de) Zusammensetzungen in blockform mit niedrigen gehalt an fettsäure seifen
ES2148123T3 (es) Composiciones cosmeticas para la prevencion y terapia de la perdida del cabello.
MY117129A (en) Method for reducing saturated fatty acids from fatty acid compositions
ES2122763T3 (es) Composiciones antimicrobianas y utilizacion de las mismas.
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
IL106288A0 (en) Skin regenerating cosmetic compositions
DE69205560D1 (de) Kosmetische und dermatologische Zusammensetzung, die Dioldiester enthält.
CA2271268A1 (en) Therapeutic and cosmetic compositions comprising an extract of crude shark liver oil, their use and method for the preparation thereof
PL337156A1 (en) Semi-solid pharmaceutic preparation containing dexketoprofene tromethamol
Hamaguchi et al. Cutaneous histopathology of Conradi‐Hunermann syndrome
IT8220757A0 (it) Sale di magnesio dell'acido chenodesossicolico e dell'acido ursodesossicolico, processo per lasua preparazione e composizioni terapeutiche che lo contengono come principio attivo.